bioAffinity Technologies, Inc. — Director's Dealing 2024

Jun 15, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: bioAffinity Technologies, Inc. (BIAF)
CIK: 0001712762
Period of Report: 2024-06-12

Reporting Person: Zannes Maria (Director, President & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-06-12	Common Stock	A	8296	$0.00	Acquired	209538	Direct

Footnotes

F1: Grant of restricted shares of common stock, par value $0.007 per share, that vest immediately.